Team:Hong Kong HKU/Design

BACKGROUND OF CRISPR/CAS 9

CRISPR-Cas (clustered regularly interspaced short palindromic repeats, CRISPR-associated) is an adoptive immune system against invasion of foreign DNA commonly found in bacteria and archaea. Just like animals' adoptive immune system, it involve memorization and removal of the invading DNA such as bacteriophage and plasmid DNA. The CRISPR-Cas system is generally encoded by chromosomal cas gene which code for CRISPR-associated proteins and an array of non-coding repeat-spacer sequence consists of sequences complementary to the invading DNA. Expression and post-processing of the array gives rise to a CRISPR RNA (crRNA) which plays a critical role in guiding the CRISPR-Cas complex1,2.

The CRISPR-Cas system can mainly be classified into three families. Our project have make use of one of the well-studied type II system, CRISPR-Cas9 originated from Streptococcus pyogenes SF 370. Similar to other types of CRISR-Cas system, CRISPR-Cas9 consists of Cas9 endonuclease and crRNA containing 20nt complementary to the target DNA, however different from type I and III, CRISPR-Cas9 also require a trans-activating crRNA (tracRNA) which form a RNA duplex with crRNA (tracRNA:crRNA) to guide the Cas9 endonuclease. Base pairing of tracRNA:crRNA with target sequence immediate upstream of protospacer adjacent motif (PAM) initiates double strand break by RuvC and NHN nuclease domain of Cas9 endonuclease1-5.

Fig. 1 (a) Schematic of wildtype CRISPR-Cas9 (b) Reprogrammed CRISPR-Cas9 using sgRNA6

To introduce lethality and enhance the efficiency of our device, a single guide RNA (sgRNA) targeting DNA polymerase III alpha subunit was adopted instead of using the wild type tracRNA and CRISPR array3. With the advantage of gBlock DNA synthesis, we have also attempted to improve the translation efficiency by optimizing the Cas9 codon for expression in E. coli using IDT oligo-optimizer.

CIRCUIT DESIGN

To ensure the efficacy of the killswitch and minimize erroneous destruction of DNA in bacteria, double regulation is essential as a tight control in our device. Thus, our circuit consists of 2 modules, one is regulated by L-arabinose and the other one is regulated by L-tryptophan. Only when both modules are on, the killswitch would be triggered to destroy the target bacteria and the DNA.

(I) Crispr cas 9: cas9 + sgRNA

The first part of the construct is composed of AraC protein, araBAD promoter and λ repressor protein CI. AraC is a gene regulatory protein which determines the transcription of CI repressor downstream of the promoter pBAD based on the L-arabinose level in the environment1. pBAD is used as it has low basal expression while maintaining large dynamic range. CI prevents lytic development so as to maintain the lysogenic state2. In the circuit, CI represses the promoter pR which is essential to perform lytic functions, and thus the expression of cas9 protein.

OFF state: + arabinose

    1. AraC originally forms a DNA loop after binding trans to the O2 and I1 half-sites3. When arabinose is present and binds to AraC, the arabinose-AraC complex binds cis to the I1 and I2 half-sites at pBAD instead to unwind the loop (see Fig. 3).

    2. pBAD is therefore induced to transcribe CI repressor. At the same time, it allows the transient derepression of pC.

    3. Since CI repressor is on, the expression of cas9 protein from pR is prevented.

Fig. 3 Binding of araC to specific half sites in the presence and absence of arabinose3

On state: - arabinose

    1. Bacteria escape from the medium and end up somewhere without arabinose supply, and arabinose taken up by the bacteria is continuously consumed by other activities pentose phosphate pathway and binary fission.

    2. When the concentration of arabinose drops, the DNA loop is formed. Hence, pBAD is repressed and so does the transcription of CI repressor.

    3. The expression of cas9 from pR is therefore induced without the repression of CI, activating the cas system.

In the second module, trpR gene and promoter pTrp promoter take their roles in activating or repressing the transcription of sgRNA. trpR codes for a tryptophan-inducible regulatory protein, trp aporepressor4. Forming a complex with its co-repressor L-tryptophan, trpR is activated and located within pTrp to block the transcription of sgRNA as a result.

OFF state: + tryptophan

    1. When tryptophan is present in the environment, it binds to trpR regulatory region and activates it (see Fig. 2).

    2. The active repressor complex then binds at pTrp so that RNA polymerase cannot bind.

    3. This prevents initiation of transcription of sgRNA downstream and switches off the cas system.

Fig. 4 Activation of trpR by tryptophan to switch off gene expression5

On state: - tryptophan

    1. When there is a lack of tryptophan in the environment, trpR is inactive.

    2. RNA polymerase can then bind to pTrp.

    3. Transcription of sgRNA is achieved and this turns the cas system on.

(II) Crispr cas 3: cas3-casABCDE + crRNA

The 2 modules of this circuit design is basically same as the previous one. For the first part, when there is arabinose, the DNA loop around pBAD is unwinded. Therefore, CI is induced to repress the transcription of cas3 as well as casABCDE. In other words, cas3 and casABCDE are expressed when the environment lacks arabinose, inhibiting the CI repressor and hence inducing pR for transcription of cas proteins. In the second part, with the presence of tryptophan, trpR is activated and it prevents crRNA to be transcribed. In order to express crRNA, tryptophan should be added to initiate the transcription.

References
[1] Chylinski, K., Le Rhun, A., & Charpentier, E. 2013. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems. RNA Biol. 10:726–737
[2] Ran, F.A. et al. 2013. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8:2281–2308.
[3] Sander, J.D. & Joung, J.K. 2014. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol. 32:347–355.
[4] M. Jineket al. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 337:816.
[5] Deltcheva, E. et al. 2011. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature. 471:602–607.
[6] Bortesi, L. & Fischer, R. 2015. The CRISPR/Cas9 system for plant genome editing and beyond. Biotechnology Advances. 33:41–52.